A Combination of Ipilimumab and Fotemustine for Treat Unresectable Locally Advanced or Metastatic Melanoma (NIBIT-M1)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2012 by Italian Network for Tumor Biotherapy.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Bristol-Myers Squibb
Information provided by (Responsible Party):
Italian Network for Tumor Biotherapy
ClinicalTrials.gov Identifier:
NCT01654692
First received: July 18, 2012
Last updated: July 28, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2013
  Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
No publications provided by Italian Network for Tumor Biotherapy

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):